AKT1 and hepatocellular carcinoma: As demonstrated in Figure 2A, the protein level of CIP2A and p-Akt decreased significantly in proportion to the lapatinib concentration in MDA-MB-231, MDA-MB-468, and HCC-1937 cells after treatment for 48 hours.